
SMS Pharmaceuticals Ltd Technical Momentum Shifts Signal Bullish Outlook
2026-05-20 08:01:55SMS Pharmaceuticals Ltd has demonstrated a notable shift in price momentum, supported by a series of bullish technical indicators and an upgrade in its MarketsMOJO rating from Sell to Hold. The stock’s recent performance, combined with positive monthly and weekly signals, suggests growing investor confidence in this small-cap pharmaceutical player.
Read More
SMS Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals
2026-05-19 08:02:51SMS Pharmaceuticals Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish trend as of May 2026. Despite a slight dip in daily price, key technical indicators present a mixed picture, reflecting both resilience and caution for investors navigating this small-cap pharmaceutical player.
Read More
SMS Pharmaceuticals Ltd Shows Strong Technical Momentum Amid Bullish Shift
2026-05-07 08:02:41SMS Pharmaceuticals Ltd has demonstrated a marked shift in price momentum, supported by a suite of bullish technical indicators across multiple timeframes. The stock’s recent performance, coupled with upgraded technical grades, signals renewed investor interest in this small-cap player within the Pharmaceuticals & Biotechnology sector.
Read More
SMS Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals
2026-05-06 08:02:20SMS Pharmaceuticals Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish trend as of early May 2026. While key indicators such as MACD and moving averages maintain positive signals, others like the monthly RSI and Dow Theory readings suggest caution. This mixed technical landscape warrants a detailed analysis for investors seeking clarity on the stock’s near-term trajectory.
Read More
SMS Pharmaceuticals Ltd is Rated Hold by MarketsMOJO
2026-04-20 10:10:03SMS Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 01 September 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 20 April 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.
Read MoreSMS Pharmaceuticals Gains 1.91%: Key Milestones and Market Momentum This Week
2026-04-18 17:03:23Key Events This Week 13 Apr: Stock opens at Rs.416.60, declines 0.71% 15 Apr: New 52-week high and all-time intraday high reached (Rs.445) 16 Apr: Price retreats by 3.17% to Rs.424.15 17 Apr: Week closes at Rs.427.60, up 0.81% on the day Week OpenRs.416.60 Week CloseRs.427.60<div class="s...
Read More
SMS Pharmaceuticals Ltd Surges 7.01% to Day's High of Rs 445 — Outperforms Sector by 5.5 Percentage Points
2026-04-15 14:00:50The Sensex advanced 1.57% on 15 Apr 2026, yet SMS Pharmaceuticals Ltd outpaced the broader market with a 7.01% gain, reaching an intraday high of Rs 445. This 5.5-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a mere market tailwind.
Read More
Broad-Based Technical Strength Lifts SMS Pharmaceuticals Ltd to 52-Week High of Rs 433.8
2026-04-15 09:44:16With a remarkable 106.56% gain over the past year, SMS Pharmaceuticals Ltd has surged to a new 52-week high of Rs 433.8, closing just 0.23% shy of this peak on 15 Apr 2026. This milestone reflects a sustained rally fuelled by strong technical momentum and a favourable market backdrop.
Read More
SMS Pharmaceuticals Ltd is Rated Hold by MarketsMOJO
2026-04-09 10:10:03SMS Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 September 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 09 April 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing.
Read MoreDisclosure Under Regulation 30 Of The SEBI (LODR) Regulations 2015.
05-Jun-2026 | Source : BSEPlease find the annexure
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
30-May-2026 | Source : BSETranscripts of the Conference call held on 27th May 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
27-May-2026 | Source : BSEAudio recording of Analysts/Investors Conference Call pertaining to the Financial Results for the fourth quarter and year ended 31st March 2026
Corporate Actions
No Upcoming Board Meetings
SMS Pharmaceuticals Ltd has declared 40% dividend, ex-date: 22 Sep 25
SMS Pharmaceuticals Ltd has announced 1:10 stock split, ex-date: 17 Dec 15
No Bonus history available
No Rights history available